 Genetic Technologies Limited NASDAQ: GENE has agreed to acquire EasyDNAs brand and distribution rights from BelHealth for 4 million in cash and stock. EasyDNA currently sells paternity, oncology, and health wellness genomics-based laboratory tests through agreements with 12 laboratories in North America, AsiaPac, and Europe. 